THIRDLAW MOLECULAR, INC.

Profile

Company Names

THIRDLAW MOLECULAR, INC.

Addresses

512 EAST TOWNSHIP LINE ROAD, 4 VALLEY SQUARE, BLUE BELL, PA 19422

Phone Numbers

334-352-9665

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2024

State Incorporated:

DELAWARE

Total Amount Raised:

$5,500,000.00

Number of Funding Rounds:

1
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
1
2025-09-02 
$5,500,000.00 
$5,500,000.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
BRIAN 
 
HALAK 
DIRECTOR
OCEANA THERAPEUTICS, INC.   |  ALIMERA SCIENCES INC   |  ORAYA THERAPEUTICS INC   |  CORTRIA CORP   |  GI DYNAMICS, INC.   |  TOBIRA THERAPEUTICS, INC.   |  CORRIDOR PHARMACEUTICALS, INC.   |  KONA MEDICAL, INC.   |  NANOTHERA CORP   |  BIONANOMATRIX INC   |  BIONANO GENOMICS, INC   |  WINDMIL THERAPEUTICS, INC.   |  SONOTHERA, INC.   |  THIRDLAW MOLECULAR, INC.
ERIC 
 
HEIL 
EXECUTIVE OFFICER, DIRECTOR
RIGHTCARE SOLUTIONS, INC.   |  BEHAVECARE INC.   |  ASTARTE MEDICAL PARTNERS, INC.   |  PROJENX, INC.   |  REJUVITAS, INC.   |  THIRDLAW MOLECULAR, INC.
CHRISTIAN 
 
SCHAFMEISTER 
EXECUTIVE OFFICER, DIRECTOR
THIRDLAW MOLECULAR, INC.
DAVID 
 
SCHEER 
DIRECTOR
AEGERION PHARMACEUTICALS, INC.   |  TENGION INC   |  PLANIT IMPACT INC.   |  DNAMX, INC.   |  REFACTOR HEALTH, INC.   |  REVELAR BIOTHERAPEUTICS, INC.   |  THYRON PHARMACEUTICALS, INC.   |  ADELA, INC.   |  THIRDLAW MOLECULAR, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2025-10-08
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2025-09-02 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#